Johnson I S
Diabetes Care. 1982 Nov-Dec;5 Suppl 2:4-12. doi: 10.2337/diacare.5.2.s4.
A summary of the exhaustive analyses of human insulin (recombinant DNA) shows chemical, structural, and biologic equivalence to pancreatic human insulin. The high degree of purity accounts for its lack of pyrogenicity and immunogenic contamination. Human insulin from both the proinsulin and chain combination methods is essentially identical. The role of proinsulin as an alternate route to human insulin, and as a new treatment for diabetes when used alone or in combination with human insulin or connecting peptide, warrants further investigation.
对人胰岛素(重组DNA)详尽分析的总结表明,其在化学、结构和生物学方面与胰腺来源的人胰岛素等效。高纯度解释了其无致热原性和免疫原性污染的原因。来自胰岛素原和链组合方法的人胰岛素基本相同。胰岛素原作为人胰岛素的替代途径,以及单独使用或与人胰岛素或连接肽联合使用时作为糖尿病新治疗方法的作用,值得进一步研究。